Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Operating Leases: 2020-2024

Historic Operating Leases for Molecular Partners Ag (MOLN) over the last 5 years, with Dec 2024 value amounting to $2.8 million.

  • Molecular Partners Ag's Operating Leases fell 9.14% to -$1,140 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1,140, marking a year-over-year decrease of 9.14%. This contributed to the annual value of $2.8 million for FY2024, which is 31.68% down from last year.
  • Per Molecular Partners Ag's latest filing, its Operating Leases stood at $2.8 million for FY2024, which was down 31.68% from $4.1 million recorded in FY2023.
  • In the past 5 years, Molecular Partners Ag's Operating Leases ranged from a high of $8.0 million in FY2020 and a low of $2.8 million during FY2024.
  • In the last 3 years, Molecular Partners Ag's Operating Leases had a median value of $4.1 million in 2023 and averaged $4.0 million.
  • Data for Molecular Partners Ag's Operating Leases shows a maximum YoY tumbled of 31.68% (in 2024) over the last 5 years.
  • Molecular Partners Ag's Operating Leases (Yearly) stood at $8.0 million in 2020, then declined by 17.97% to $6.5 million in 2021, then decreased by 23.13% to $5.0 million in 2022, then dropped by 19.23% to $4.1 million in 2023, then tumbled by 31.68% to $2.8 million in 2024.